| Application no. and date | 03813233.8 (espacenet) (Federated) (European Patent Register), 20031203 | | Patent/reg. no. and date | DK/EP 1572173, 20100428 | | Publication date | 20050914 | | Priority no. and date | US 433491 P, 20021213, GB 0302657, 20030205 | | EP pub. no. and date |
EP 1572173 20050914 | | Effective date | | | Applicant/owner | Warner-Lambert Company LLC, 235 East 42nd Street
New York, NY 10017, US | | Applicant ref. no. | P81003925DK00E | | Inventor | Taylor, C. P. Jr., Pfizer Global Res. andDev.,
Ann Arbor Lab.
2800 Plymouth Road,
Ann Arbor, MI 48105, US,
Thorpe, A. J., Pfizer Global Res. and Dev.,
Ann Arbor Lab.
2800 Plymouth Road,
Ann Arbor, MI 48105, US,
Westbrook, S. L., Pfizer Global Res. and Dev.,
Ramsgate Road
Sandwich, Kent CT139NJ, GB,
Wustrow, D. J., Pfizer Global Res. andDev.,
Ann Ar bor Lab.
2800 Plymouth Road,
Ann Arbor, MI 48105, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/00 (2006.01) , A61K 31/195 (2006.01) , A61K 31/197 (2006.01) , A61P 13/00 (2006.01) | | Title | Alpha-2-delta-ligand til behandling af symptomer i den nedre urinvej | | Int. application no. | IB2003005729 | | Int. publication no. | WO2004054560 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
